A Phase 1b/2 Study of JNJ-90014496 in Adult Participants with B-cell Non-Hodgkin Lymphoma
90014496LYM1001
Phase 1 other active
Quick answer
A Phase 1b/2 Study of JNJ-90014496 in Adult Participants with B-cell Non-Hodgkin Lymphoma for Non-Hodgkin Lymphoid Malignancies is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Non-Hodgkin Lymphoid Malignancies
- Phase
- Phase 1
- Modality
- other
- Status
- active